Company Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Shenzhen YHLO Biotech Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Medical Equipment

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
23.79 ^CNY	+3.93%		+8.83%	+4.02%

Apr. 19	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 23	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 1,837

CNY in Million	2022	Weight	2023	Weight	Delta
Self-produced Reagents 47.0 %	666	16.7 %	966	47.0 %	+44.95%
Self-produced New Coronavirus Products 16.7 %	2,725	68.5 %	342	16.7 %	-87.46%
Agent Reagent 12.0 %	222	5.6 %	247	12.0 %	+11.20%
Self-produced Consumables 9.2 %	114	2.9 %	188	9.2 %	+64.74%
Self-produced Instruments 8.3 %	123	3.1 %	171	8.3 %	+38.36%
Agent Consumables 3.8 %	66	1.7 %	79	3.8 %	+18.88%
Other Business 1.7 %	51	1.3 %	35	1.7 %	-32.16%
Agent Instrument 1.2 %	12	0.3 %	25	1.2 %	+113.78%
Software Services 0.1 %	0	0.0 %	1	0.1 %	+217.58%

CNY in Million	2022	Weight	2023	Weight	Delta
China 91.9 %	2,197	55.9 %	1,854	91.9 %	-15.62%
Overseas 8.1 %	1,733	44.1 %	164	8.1 %	-90.51%

Managers	Title	Age	Since
Yong Bo Song CEO	Chief Executive Officer	40	09-12-31
Xiao Hui Ye CHM	Chairman	46	12-11-30
Kun Hui Hu CHM	Chairman	33	12-11-30
Chun Gen Qian CTO	Chief Tech/Sci/R&D Officer	42	15-09-30
Hui Chong Wang BRD	Director/Board Member	42	19-03-31
Ya Nan Shao IRC	Investor Relations Contact	31	-
Ming Yang Wang SEC	Corporate Secretary	35	23-10-25
Yu Jin Xiao PRN	Corporate Officer/Principal	48	12-11-30

Members of the board	Title	Age	Since
Chun Mao Shi BRD	Director/Board Member	54	23-10-09
Kun Hui Hu CHM	Chairman	33	12-11-30
Yong Bo Song CEO	Chief Executive Officer	40	09-12-31
Deng Ming Liu BRD	Director/Board Member	49	19-06-27
Wen Ya Yang BRD	Director/Board Member	45	15-06-30
Xiao Hui Ye CHM	Chairman	46	12-11-30
Chun Gen Qian CTO	Chief Tech/Sci/R&D Officer	42	15-09-30
Yu Jin Xiao PRN	Corporate Officer/Principal	48	12-11-30
Xue Jin Li BRD	Director/Board Member	58	21-11-03
Hui Chong Wang BRD	Director/Board Member	42	19-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	568,308,500	213,824,874 ( 37.62 %)	0	37.62 %

Name	Equities	%	Valuation
Lin He 7.559 %	20,237,000	7.559 %	68 M ¥
Jiaxing Ruiyao Equity Investment LP 6.535 %	17,495,450	6.535 %	59 M ¥
Hainan Shuofeng Private Equity Fund Management Pp LP 4.201 %	11,247,147	4.201 %	38 M ¥
Yiyu Yao 3.434 %	9,192,879	3.434 %	31 M ¥
Crystal Stream Beijing Investment Consulting Co. Ltd. 2.674 %	7,157,583	2.674 %	24 M ¥
Changsheng Fund Management Co., Ltd. 2.408 %	6,445,178	2.408 %	22 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 2.325 %	6,225,454	2.325 %	21 M ¥
Hainan Shuofeng PE Fund Management Pp LP 2.131 %	5,704,122	2.131 %	19 M ¥
LAV Management Co., Ltd. 2.104 %	5,632,997	2.104 %	19 M ¥
Penghua Fund Management Co., Ltd. 1.954 %	5,232,218	1.954 %	18 M ¥

Name	Equities	%	Valuation
Kun Hui Hu 89.41 %	268,612,904	89.41 %	903 M ¥
Shenzhen Huadesai Investment Consulting Partnership 5.456 %	16,390,500	5.456 %	55 M ¥
Shenzhen Yikanghua Investment Consulting Partnership 3.295 %	9,898,000	3.295 %	33 M ¥
Shenzhen Jinruikang Investment Consulting Partnership 0.7209 %	2,165,800	0.7209 %	7 M ¥
Shenzhen Ruihuajian Investment Consulting Partnership 0.5643 %	1,695,400	0.5643 %	6 M ¥
Shenzhen Longkangsheng Investment Consulting Partnership 0.5529 %	1,661,100	0.5529 %	6 M ¥

Shenzhen YHLO Biotech Co., Ltd.

Building 1, YHLO Biotech Plant Baolong 2nd Road, Baolong Street

518116, Shenzhen

+86 755 2647 3359

http://www.szyhlo.com

address Shenzhen YHLO Biotech Co., Ltd.(688575)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.89 CNY

Average target price

28.67 CNY

Spread / Average Target

+25.24%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Equipment

	1st Jan change	Capi.
SHENZHEN YHLO BIOTECH CO., LTD.	+0.09%	1.8B
SHOCKWAVE MEDICAL, INC.	+72.39%	12.32B
PENUMBRA, INC.	-18.22%	7.96B
MASIMO CORPORATION	+16.84%	7.25B
GETINGE AB	+3.17%	5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+8.16%	5.11B
APT MEDICAL INC.	+19.97%	4.28B
ASAHI INTECC CO., LTD.	-19.84%	4B
INARI MEDICAL, INC.	-42.79%	2.15B
SKAN GROUP AG	+1.24%	2.01B

Medical Equipment